Biotechnology news from around the world.
FDA bans Bayer poultry antibiotic
July 28 – The US Food and Drug Administration has banned the use of Baytril, Bayer's poultry antibiotic, citing the product interferes with the diagnosis of food poisoning in human patients. Baytril, a fluoroquinilone based drug, is used to prevent the growth of drug-resistant germs within poultry that infect people. The ban is the first time the FDA has withdrawn an antibiotic drug for animals based on its impacts on humans.
[Source: Reuters]
Top generics push branded drug patents
August 2 – A study by Kline and Company has suggested that large generic companies are actively contesting brand-name patents in order to bring the generic versions to market sooner. Generic products are usually marketed upon patent expiry of the brand-name product, however recent acquisitions have greatly expanded the generic markets and provided sufficient resources to contest brand-name patents.
[Source: PRNewsWire]
